Cure Ventures is a life sciences venture capital firm focusing on investing in de novo company formation around groundbreaking curative technologies. We emphasize the importance of collaboration alongside entrepreneurs to advance drug discovery and bring innovative therapeutics to patients suffering life-altering diseases.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions